☆ 4.7 Article

Bayesian Sequential Design for Identifying and Ranking Effective Patient Subgroups in Precision Medicine in the Case of Counting Outcome Data with Inflated Zeros

JOURNAL OF PERSONALIZED MEDICINE (2023)

Related references

Note: Only part of the references are listed.

Article Medicine, General & Internal

Rapid rEcognition of COrticosteRoiD resistant or sensitive Sepsis (RECORDS): study protocol for a multicentre, placebo-controlled, biomarker-guided, adaptive Bayesian design basket trial

Jerome Fleuriet et al.

Summary: The RECORDS trial aims to define endotypes associated with adults with sepsis responsiveness to corticosteroids. The trial will randomly assign 1800 adults with sepsis to receive a 7-day course of hydrocortisone and fludrocortisone or their placebos. The primary outcome will be 90-day death or persistent organ dysfunction.

BMJ OPEN (2023)

Add to Collection

Article Biology

Bayesian group sequential enrichment designs based on adaptive regression of response and survival time on baseline biomarkers

Yeonhee Park et al.

Summary: Precision medicine relies on the idea that only a subpopulation of patients is sensitive to a particular targeted agent and may benefit therapeutically. This paper introduces a Bayesian randomized group sequential enrichment design for comparing an experimental treatment to a control based on survival time and using early response as an ancillary outcome. The design aims to identify a treatment-sensitive subpopulation and determine the superiority of the experimental treatment in that subpopulation, providing a reliable and powerful tool for precision medicine.

BIOMETRICS (2022)

Add to Collection

Article Health Care Sciences & Services

Enrichment Bayesian design for randomized clinical trials using categorical biomarkers and a binary outcome

Valentin Vinnat et al.

Summary: Background adaptive clinical trials can select a potential target population without conducting separate trials. We proposed a Bayesian design to restrict the inclusion to a subset of patients who are likely to benefit the most from the treatment. The enrichment rules allowed for faster detection of treatment-by-subset interactions compared to traditional criteria.

BMC MEDICAL RESEARCH METHODOLOGY (2022)

Add to Collection

Article Statistics & Probability

Improved Doubly Robust Estimation in Learning Optimal Individualized Treatment Rules

Yinghao Pan et al.

Summary: Individualized treatment rules recommend treatment based on patient characteristics. An improved doubly robust estimator is proposed for optimal ITRs, achieving the smallest variance among a class of doubly robust estimators when the propensity score model is correctly specified. Simulation studies show better results than current popular methods.

JOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION (2021)

Add to Collection

Article Statistics & Probability

Optimal Individualized Decision Rules Using Instrumental Variable Methods

Hongxiang Qiu et al.

Summary: This study discusses the development of individualized decision rules in settings where some confounders may not have been measured but a valid binary instrument is available for a binary treatment. It focuses on individualized treatment rules, especially in settings where direct intervention on treatment is feasible, and also considers a scenario where intervening on treatment is not feasible but encouraging treatment is possible. Optimal interventions prioritize individuals who will benefit most from treatment, especially when treatment is a limited resource.

JOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION (2021)

Add to Collection

Article Pharmacology & Pharmacy

A pragmatic adaptive enrichment design for selecting the right target population for cancer immunotherapies

Anh Nguyen Duc et al.

Summary: This study presents the design of an adaptive enrichment design (AED) with a binary endpoint in cancer immunotherapy, aiming to address uncertainties regarding the optimal target population for a novel drug by allowing data-driven selection of one or more biomarker subpopulations at an interim analysis. Operating characteristics are discussed, including the concept of a minimal detectable difference in the setting of AED.

PHARMACEUTICAL STATISTICS (2021)

Add to Collection

Article Critical Care Medicine

Ventilation management and clinical outcomes in invasively ventilated patients with COVID-19 (PRoVENT-COVID): a national, multicentre, observational cohort study

Michela Botta et al.

Summary: This national study in the Netherlands investigated the ventilation management of invasively ventilated patients with COVID-19 during the first month of the outbreak. Lung-protective ventilation with low tidal volume and prone positioning were common practices. The study provides valuable insights for future trials and interpretation of findings in this patient population.

LANCET RESPIRATORY MEDICINE (2021)

Add to Collection

Article Statistics & Probability

Estimation of Optimal Individualized Treatment Rules Using a Covariate-Specific Treatment Effect Curve With High-Dimensional Covariates

Wenchuan Guo et al.

Summary: The proposed method aims to estimate the covariate-specific treatment effect curve, enabling individualized treatment selection based on subgroup identification, and provides flexibility and a unified inferential tool in depicting associations between treatment and baseline covariates in the presence of high-dimensional covariates.

JOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION (2021)

Add to Collection

Article Mathematics, Interdisciplinary Applications

Adaptive Enrichment Designs in Clinical Trials

Peter F. Thall

Summary: Adaptive enrichment designs for clinical trials have various functions such as identifying patient subgroups, selecting or comparing treatments based on interim data, or changing entry criteria; the structure of these designs depends on goals, patient heterogeneity, treatment effects, and practical constraints; this article covers basic concepts and different types of enrichment, with numerical examples for qualitative different cases involving treatment-biomarker interactions.

ANNUAL REVIEW OF STATISTICS AND ITS APPLICATION, VOL 8, 2021 (2021)

Add to Collection

Article Critical Care Medicine

Hospital-Free Days: A Pragmatic and Patient-centered Outcome for Trials among Critically and Seriously Ill Patients

Catherine L. Auriemma et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2021)

Add to Collection

Article Pharmacology & Pharmacy

Multi-stage adaptive enrichment trial design with subgroup estimation

Neha Joshi et al.

JOURNAL OF BIOPHARMACEUTICAL STATISTICS (2020)

Add to Collection

Review Oncology

New clinical trial designs in the era of precision medicine: An overview of definitions, strengths, weaknesses, and current use in oncology

Perrine Janiaud et al.

CANCER TREATMENT REVIEWS (2019)

Add to Collection

Article Medicine, General & Internal

Effect of Selepressin vs Placebo on Ventilator- and Vasopressor-Free Days in Patients With Septic Shock: The SEPSIS-ACT Randomized Clinical Trial

Pierre-Francois Laterre et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2019)

Add to Collection

Article Medicine, General & Internal

Hydrocortisone plus Fludrocortisone for Adults with Septic Shock

D. Annane et al.

NEW ENGLAND JOURNAL OF MEDICINE (2018)

Add to Collection

Article Mathematical & Computational Biology

Random forests of interaction trees for estimating individualized treatment effects in randomized trials

Xiaogang Su et al.

STATISTICS IN MEDICINE (2018)

Add to Collection

Article Computer Science, Interdisciplinary Applications

An unsupervised machine learning method for discovering patient clusters based on genetic signatures

Christian Lopez et al.

JOURNAL OF BIOMEDICAL INFORMATICS (2018)

Add to Collection

Article Biology

A subgroup cluster-based Bayesian adaptive design for precision medicine

Wentian Guo et al.

BIOMETRICS (2017)

Add to Collection

Article Statistics & Probability

Subgroup selection in adaptive signature designs of confirmatory clinical trials

Zhiwei Zhang et al.

JOURNAL OF THE ROYAL STATISTICAL SOCIETY SERIES C-APPLIED STATISTICS (2017)

Add to Collection

Article Oncology

Precision medicine needs randomized clinical trials

Everardo D. Saad et al.

NATURE REVIEWS CLINICAL ONCOLOGY (2017)

Add to Collection

Article Statistics & Probability

Modeling data with a truncated and inflated Poisson distribution

Min-Hsiao Tsai et al.

STATISTICAL METHODS AND APPLICATIONS (2017)

Add to Collection

Article Biology

Bayesian population finding with biomarkers in a randomized clinical trial

Satoshi Morita et al.

BIOMETRICS (2017)

Add to Collection

Article Critical Care Medicine

Liberal Manipulation of Ventilator Settings and Its Impact on Tracheostomy Rate and Ventilator-Free Days

Ariel M. Modrykamien et al.

RESPIRATORY CARE (2016)

Add to Collection

Article Pharmacology & Pharmacy

Bayesian adaptive patient enrollment restriction to identify a sensitive subpopulation using a continuous biomarker in a randomized phase 2 trial

Shoichi Ohwada et al.

PHARMACEUTICAL STATISTICS (2016)

Add to Collection

Article Pharmacology & Pharmacy

Hyperbaric oxygen brain injury treatment (HOBIT) trial: a multifactor design with response adaptive randomization and longitudinal modeling

Byron J. Gajewski et al.

PHARMACEUTICAL STATISTICS (2016)

Add to Collection

Article Health Care Sciences & Services

Ranking treatments in frequentist network meta-analysis works without resampling methods

Gerta Ruecker et al.

BMC MEDICAL RESEARCH METHODOLOGY (2015)

Add to Collection

Article Mathematical & Computational Biology

Biomarker-based Bayesian randomized phase II clinical trial design to identify a sensitive patient subpopulation

Satoshi Morita et al.

STATISTICS IN MEDICINE (2014)

Add to Collection

Article Medicine, Research & Experimental

Bayesian hierarchical modeling of patient subpopulations: Efficient designs of Phase II oncology clinical trials

Scott M. Berry et al.

CLINICAL TRIALS (2013)

Add to Collection

Article Medicine, Research & Experimental

Adaptive enrichment with subpopulation selection at interim: Methodologies, applications and design considerations

Sue-Jane Wang et al.

CONTEMPORARY CLINICAL TRIALS (2013)

Add to Collection

Article Mathematical & Computational Biology

Designing a pilot sequential multiple assignment randomized trial for developing an adaptive treatment strategy

Daniel Almirall et al.

STATISTICS IN MEDICINE (2012)

Add to Collection

Article Health Care Sciences & Services

Graphical methods and numerical summaries for presenting results from multiple-treatment meta-analysis: an overview and tutorial

Georgia Salanti et al.

JOURNAL OF CLINICAL EPIDEMIOLOGY (2011)

Add to Collection

Article Mathematical & Computational Biology

A method to estimate treatment efficacy among latent subgroups of a randomized clinical trial

Lily L. Altstein et al.

STATISTICS IN MEDICINE (2011)

Add to Collection

Article Mathematical & Computational Biology

Subgroup identification based on differential effect search-A recursive partitioning method for establishing response to treatment in patient subpopulations

Ilya Lipkovich et al.

STATISTICS IN MEDICINE (2011)

Add to Collection

Article Mathematical & Computational Biology

Subgroup identification from randomized clinical trial data

Jared C. Foster et al.

STATISTICS IN MEDICINE (2011)

Add to Collection

Article Mathematical & Computational Biology

Detecting qualitative interaction: A Bayesian approach

Emine Oezguer Bayman et al.

STATISTICS IN MEDICINE (2010)

Add to Collection

Article Pharmacology & Pharmacy

Clinical Trial Designs for Predictive Biomarker Validation: One Size Does Not Fit All

Sumithra J. Mandrekar et al.

JOURNAL OF BIOPHARMACEUTICAL STATISTICS (2009)

Add to Collection

Article Oncology

Clinical Trial Designs for Predictive Biomarker Validation: Theoretical Considerations and Practical Challenges

Sumithra J. Mandrekar et al.

JOURNAL OF CLINICAL ONCOLOGY (2009)

Add to Collection

Article Oncology

Adaptive signature design: An adaptive clinical trial design for generating and prospectively testing a gene expression signature for sensitive patients

B Freidlin et al.

CLINICAL CANCER RESEARCH (2005)

Add to Collection

© Peeref 2019-2024. All rights reserved.